Compare RAIL & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAIL | BHST |
|---|---|---|
| Founded | 1901 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Railroads | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.1M | 162.2M |
| IPO Year | N/A | N/A |
| Metric | RAIL | BHST |
|---|---|---|
| Price | $8.40 | $6.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 156.3K | 108.7K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.45 | N/A |
| Revenue | ★ $513,120,000.00 | $32,720,000.00 |
| Revenue This Year | $2.94 | $116.40 |
| Revenue Next Year | $6.92 | $55.91 |
| P/E Ratio | $3.35 | ★ N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $4.31 | $4.72 |
| 52 Week High | $13.64 | $12.80 |
| Indicator | RAIL | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 40.61 |
| Support Level | $7.27 | $6.25 |
| Resistance Level | $7.94 | $7.20 |
| Average True Range (ATR) | 0.34 | 0.80 |
| MACD | 0.09 | 0.09 |
| Stochastic Oscillator | 78.47 | 28.80 |
FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.